NFKB1 and acute respiratory distress syndrome: siRNA with high specificity, however, can target and decompose the complementary NF-κB mRNA [9], making it a perfect candidate for inhibiting the initially inflammatory cascade during ALI development via inhibition of NF-κB pathway activation.